Steven Woratyla, MD
Vascular Surgery · Lancaster, PANPI 1710997085
Payments from drug & device makers
Across 163 payments — averaging $40.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bard Peripheral Vascular, Inc.$1K
- Johnson & Johnson$1K
- Endologix LLC$681
- Smith+Nephew$537
- Penumbra, Inc.$320
- Medtronic$314
- plus $2K from 27 others
What the payments were for
- Travel & lodging$2243%
- Food & beverage$6,36897%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bard Peripheral Vascular, Inc. | 22 | $1,447 |
| Johnson & Johnson(2 entities) | 48 | $1,158 |
| Endologix LLC | 5 | $681 |
| Smith+Nephew | 29 | $537 |
| Penumbra, Inc. | 3 | $320 |
| Medtronic(2 entities) | 8 | $314 |
| W. L. Gore & Associates, Inc. | 2 | $303 |
| Janssen Scientific Affairs, LLC | 2 | $228 |
| Baxter Healthcare | 4 | $210 |
| Tactile Systems Technology Inc | 4 | $182 |
| Inari Medical, Inc. | 1 | $178 |
| Silk Road Medical, Inc. | 1 | $177 |
| Melinta Therapeutics, LLC | 4 | $158 |
| Cordis US CORP. | 1 | $111 |
| Lemaitre Vascular, Inc. | 7 | $100 |
| Amniox Medical, Inc. | 2 | $95 |
| Organogenesis Inc. | 2 | $43 |
| Integra Lifesciences Corporation | 2 | $42 |
| Vertex | 2 | $32 |
| Mozarc Medical US LLC | 1 | $31 |
| Solventum Corporation | 1 | $29 |
| KCI USA, Inc. | 1 | $27 |
| Bolton Medical Inc | 1 | $23 |
| Covidien LP | 1 | $21 |
| Abbott | 1 | $21 |
| Angiodynamics, Inc. | 1 | $21 |
| Getinge USA Sales, LLC | 1 | $18 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Arjo Inc. | 1 | $15 |
| Avanos Medical | 1 | $15 |
| Avita Medical Americas, LLC | 1 | $15 |
| Urgo Medical North America, LLC | 1 | $14 |
| Portola Pharmaceuticals, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XARELTO$345
- Alto Abdominal Stent Graft System$265
- Torus Stent Graft System$255
- ENDOCROSS Device$255
- LUTONIX$243
- FLOWTRIEVER CATHETER, S$178
- CT THROMBECTOMY SYSTEM KIT$178
- ENROUTE Transcarotid Neuroprotection System$177
- ENROUTE Transcarotid Stent$177
- Lutonix Drug Coated Balloon$160
- VIABAHN Endoprosthesis with PROPATEN Bioactive Surface$155
- RUBY Coil$152
- AFX$150
- VIABAHN VBX Balloon Expandable Endoprosthesis$149
- Indigo$148
- Penumbra Ruby Coil$148
- FLEXITOUCH$134
- ACTITOUCH$134
- ENTRE$134
- No Related Product$121
How this compares
$6,593 in reported general payments places this provider in the 60th percentile of 236 vascular surgery providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 31 | $22,030 |
| EliquisApixaban | 30 | $19,551 |
| Pentoxifylline | 105 | $4,337 |
| Cilostazol | 103 | $2,064 |
| ClopidogrelClopidogrel Bisulfate | 136 | $994 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 36 | $532 |
| Cephalexin | 13 | $336 |
| JantovenWarfarin Sodium | 25 | $97 |
| Oxycodone Hcl | 14 | $51 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $1,158 | $22,03031 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 236 vascular surgery providers in Pennsylvania.
Other vascular surgery in Lancaster
- Meghan DermodyLancaster$321K
- David CziperleLancaster$37K
- Thomas O ConnorLancaster$14K
- Darren SchneiderPhiladelphia$1M
- Nathan LiangPittsburgh$551K
- Elizabeth GenovesePhiladelphia$475K
- Shang LohPhiladelphia$350K
- Paul FoleyDoylestown$257K
- Michel MakarounPittsburgh$241K
- Edward WooPhiladelphia$189K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.